Blog / Archives
Rayno Biopharmaceuticals Portfolio 2/09/09-1/27/12
Rayno Life Science Biopharmaceutical Picks Beat All Sector Averages Life Science Market Hits 10 Year High Tracked by IBB ($115.51), and Up 46% Over 5 years Highlights of Rayno Biopharma Portfolio...
Rayno Life Science Portfolio: Another Buyout- MITI Goes for $1.16B
M&A Trend Picks Up Steam The beat goes on as Amgen agrees to buy Micromet (MITI $10.95) for $1.16B.Micromet is focused on treatment of hematologic malignancies with its BiTE monoclonal antibody...
Roche Bid for Illumina (ILMN) Drives Biotech Sector to New Highs
M&A Theme Provides Underlying Bid to Market Roche Holding, the most diversified diagnostics and pharmaceutical Company with an aggressive leveraged strategy for the molecular basis of disease...
“January Effect” Traders: Take Some Profits
If you followed our trades from November /December you made at least 20% so why push it? The Rayno Life Science Portfolio is down 0.75% today in a choppy market. Our mid-cap biopharmaceutical index...
“January Effect” Rolls On with Biotech Stocks Up Over 1%, 9.3% MTD
Seems a Bit Frothy Large and mid-cap biopharmaceutical stocks continued to surge today with the bellwether ETF IBB ($114) hitting one year highs of $114.15 today. Many of our recent focus picks also...
Trends from the JPMorgan Healthcare Conference 2012
Healthcare: Broad Trends and Business Concepts for 2012 Last year we published an overview of trends for the 2011 JPMorgan Conference. Here is a very brief review from this year's Conference: The...
“January Effect” Rally: A Cliched Trade That Really Works
You read about it every year, and always there are skeptics, but in Q4 2011 to Q 2012 the "January effect " rally for small cap and life science stocks were big winners. Why does this happen? Not so...
JPMorgan Healthcare Conference: Life Science Tools Rally
Life Science stocks got a boost from news and presentations at the J.P.Morgan Healthcare Conference and most stocks from the Rayno Life Science Portfolio were up.(see our "January Effect" trades...
Rayno SnowBlog: High and Dry- Dry Curse of La Nina is Back 1/31
We had a powder weekend in Mammoth with 3ft Jan20-22 but nothing on the horizon for 10 days. Check Alta, Northwest like Mt Baker or BC and maybe Big Sky....
Biotechnology Stock Review 2011:Update 1/2/12
Here are some key points from our 2011 Biotech Stock Review posted in Investor Uprising: Winners from the 2011 Rayno Life Science Portfolio: Abaxis (ABAX), Alexion(ALXN), Amgen (AMGN), Biogen(BIIB),...